Processa Pharmaceuticals Inc (NAS:PCSA)
$ 1.19 -0.12 (-9.16%) Market Cap: 3.88 Mil Enterprise Value: -1.58 Mil PE Ratio: 0 PB Ratio: 0.57 GF Score: 30/100

Processa Pharmaceuticals Inc Fireside Chat Transcript

Dec 20, 2023 / 09:30PM GMT
Release Date Price: $8.4 (-19.08%)
Operator

Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to Processa Pharmaceuticals clinical update fireside chat. (Operator Instructions)

Participants on this call are advised that the audio of this conference call is being broadcast live over the Internet. A webcast replay of the call will be available approximately one hour after the call ends through June 20, 2024.

I would now like to turn the call over to Dr. Michael Beaubaire of Core IR, the company's Investor Relations firm. Please go ahead, sir.

Michael Beaubaire Core IR;Chief Healthcare Strategist

Good afternoon. I am Dr. Michael Beaubaire, Chief Strategist Officer of Core IR, and thank you for participating in today's conference call. Joining me from Processa Pharmaceuticals' leadership team are George Ng, Chief Executive Officer, and Dr. David Young, Pharm.D., Ph.D., President of R&D.

During this call, management will be making forward-looking statements, including statements that address Processa's expectations for future performance or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot